Arm-twisting by Trump must be resisted

Discretion has never been one of Donald Trump’s virtues. In fact, he has built his macho image assiduously by playing bully.

Published: 09th April 2020 04:00 AM  |   Last Updated: 09th April 2020 07:29 AM   |  A+A-

US President Donald Trump (Photo | AP)

Discretion has never been one of Donald Trump’s virtues. In fact, he has built his macho image assiduously by playing the bully. However, after the enthusiastic welcome of a stadium full of cheering Amdavadis, organised by PM Narendra Modi for the US President in late February, India expected more respectful treatment. The skirmish started after India imposed a ban on 24 pharmaceutical drugs on March 3 after the coronavirus pandemic began disrupting supply chains globally.

One of them, hydroxychloroquine (HCQ), inexpensive treatment for malaria and rheumatoid arthritis, has been touted by Trump as a possible antidote to suppressing the deadly COVID-19. Trump sought a reversal of the ban for HCQ, but in the most intemperate language. “If he (the Indian PM) doesn’t allow it (HCQ) to come out that would be okay but, of course, there may be retaliation. Why wouldn’t there be?” Trump boasted at a press conference.

By Tuesday morning, the export restrictions on most drugs had been lifted. As a face-saver, the statement said exports were being opened not only for the US but also for other “nations badly affected by the virus”. This is not the first instance of Trump’s strong-arm tactics. In September 2018, when the US was attempting to isolate Iran, Trump demanded India stop import of Iranian oil. Though the terms and price were beneficial to India, the US arm-twisted us into compliance. Earlier, removing tariffs imposed on imported Harley-Davidson bikes was also made a prestige issue. With India being the largest producer of generic drugs and HCQ, it is understandable that we take a humane view to supplying crucial medicines to those global hotspots where lives can be saved.

This must be balanced though with our own needs for a steady supply to domestic markets. If hydroxychloroquine does turn out to be a gamechanger to stem COVID-19, our capacity to produce 100 tonnes a month would put India ahead of the curve. In this context, the US has no right to meddle with India’s export policy, and our government would do well not to bend to such arm-twisting.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp